Submit Article

Global Biopharmaceutical Third Party Logistics Market: Industry Analysis and Forecast (2019-2027)

Global Biopharmaceutical Third Party Logistics Market size was valued at US$ 94,400 Mn in 2019 and the total revenue is expected to grow at 5.7% through 2019 to 2027, reaching nearly US$ 147,086.19 Mn in the forecast period.

 

Global Biopharmaceutical Third Party Logistics Market

 

Global Biopharmaceutical Third Party Logistics Market

To know about the Research Methodology :- Request Free Sample Report

The report has covered the market trends from 2015 to forecast the market through 2027. 2019 is considered a base year however 2020’s numbers are on the real output of the companies in the market. Special attention is given to 2020 and the effect of lockdown on the demand and supply, and also the impact of lockdown for the next two years on the market. Some companies have done well in lockdown also and specific strategic analysis of those companies is done in the report.
Global Biopharmaceutical Third Party Logistics Market Overview:

Biopharmaceutical Third Party Logistics is a service that offers import and export of biopharmaceutical ingredients by the pharmaceutical companies by the involvement of third-party logistics. The various functions of third-party logistics are inventory management, warehousing, and fulfillment to a third-party business authority. This process involves on the contract basis between two business operations.
Global Biopharmaceutical Third Party Logistics Market Dynamics:

The Biopharmaceutical Third Party Logistics Market is predictable to grow with a CAGR of 5.7% during the forecast period. The growth of the market is attributed to the building of a strong network in sales with new launches around the world. Moreover, the launching of biosimilar drugs with growing chronic diseases is likely to fuel the market growth in the forecast period. Biosimilar drugs are economic and due to this factor, they are creating dominance in the market.

Technological innovation in warehousing like temperature management, mobile cloud solutions, data mining, real-time monitoring, and warehouse robotics is the key reason to boost the market growth. Further, these advancements are innovated to decrease human errors, reduce damages and complexity during transportation, and maintain the quality of goods like factory-made. Further, warehousing robotics is widely preferred as it reduces the labor cost while increasing warehouse throughput. This factor is increasing the adoption of robotics in warehousing due to reducing operational costs.

In 2019, Amazon manufactured 100,000 robotic systems together with 800 Pegasus and Xanthus robotics systems to fulfill around 25 centers around the US. Robotics monitoring is greatly influencing the market as pharmaceutical ingredients are temperature sensitive and require continuous monitoring during transit.
Moreover, companies like DHL launched a new Android and IOS app named LifeTrack which helps in monitoring the cold chain tracking platform for healthcare and pharmaceutical ingredient shipment. The app has the function to send the alarm to the shipper during the complexity. And this factor is likely to boost the Biopharmaceutical Third Party Logistics Market during the forecast period.
Global Biopharmaceutical Third Party Logistics Market Segment Analysis:

Non-cold chain is dominating the Supply Chain segment of Global Biopharmaceutical Third Party Logistics Market:

The non-cold chain segment is gaining more attention as compared to the cold chain segment and has accounted for the largest revenue share of 81.3% in 2020 in the Biopharmaceutical Third Party Logistics Market. The factors attributing to the growth of the market are the large-scale distribution of medicines and vaccines, high visibility, low-cost optimization, higher returns with lower risk, and these factors also help in building a strong logistic network. Further, the non-cold chain supply chain does not require continuous monitoring of temperatures like biologics and this factor is likely to fuel the growth of the market. Also, the non-cold supply chain is the most preferred mode of transit.

The Cold Chain segment is growing at a significant pace in the forecast period with a CAGR of 8.9%. Biologics are greatly influencing the cold chain segment as they have gained more attention in the market. Further, the cold chain supply chain is also used for the transportation of blood products, marker testing, cellular therapies, organ transportation, vaccines, and regenerative medicines.

The warehousing and Storage segment is considered to supplement the growth of the Global Biopharmaceutical Third Party Logistics Market.

The warehousing and storage segment is dominating the Biopharmaceutical Third Party Logistics Market and accounted for 47.2% in 2020. The warehousing and storage segment is greatly influenced by the pharmaceutical and healthcare industries. To reduce the overall cost of end-product life science companies binding with third party logistics. Moreover, due to excess demand, the transit companies have increased the value-added services like warehousing and packaging to reduce the complexity and rush. Further, the companies have installed the barcode scanners and robots for the pic and drop facility for loading and unloading of the products.

The packaging facility is the main department of warehousing the storage segment as it requires high-quality containers that are damage resistant with waterproof coating as per the regulatory standards. And these factors are further fueling the demand of the warehouse and storage segment of the Global Biopharmaceutical Third Party Logistics Market.
Global Biopharmaceutical Third Party Logistics Market Regional Insights:

North America is dominating the global biopharmaceutical third party logistics market, with the largest market share of 43.5% in the forecast period. The growth is dominated by the increasing import and export of pharmaceutical ingredients, drugs, biologics, vaccines, and other. Furthermore, the investment in the healthcare sector by the government and the private organization together with technological advancement in the transport industry are supplementing the growth of the market in favorable aspects.

Asia Pacific has estimated a substantial market share of USD 18200 million in 2020 and is likely to grow with a CAGR of 8.1% during the forecast period. The occurrence of chronic diseases like diabetes, obesity, cardiovascular diseases are grabbing more attention in the region hence this factor is creating more demand for medicine and drugs in a growing population. In addition, high technologies and advanced services with the growing economic condition of the region are the factors likely to supplement the growth of the market during the forecast period.

Global Biopharmaceutical Third Party Logistics Market

The objective of the report is to present a comprehensive analysis of the Global Biopharmaceutical Third Party Logistics Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding the Global Biopharmaceutical Third Party Logistics Market dynamics, structure by analyzing the market segments and project the Global Biopharmaceutical Third Party Logistics Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Global Biopharmaceutical Third Party Logistics Market make the report investor’s guide.
Global Biopharmaceutical Third Party Logistics Market Scope: Inquire before buying

Global Biopharmaceutical Third Party Logistics Market
Global Biopharmaceutical Third Party Logistics Market, by Region

• North America
o US
o Canada
o Mexico
• Europe
o U.K
o France
o Germany
o Italy
o Spain
o Sweden
o CIS Countries
o Rest of Europe
• Asia Pacific
o China
o India
o Japan
o South Korea
o Australia
o ASEAN
o Rest of Asia Pacific
• The Middle East and Africa
o South Africa
o GCC Countries
o Egypt
o Nigeria
o Rest of ME&A
• South America
o Brazil
o Argentina
o Rest of South America
Global Biopharmaceutical Third Party Logistics Market Key Player

• FedEx.
• DHL International GmbH
• SF Express
• United Parcel Service of America, Inc.
• AmerisourceBergen Corporation
• DB Schenker
• KUEHNE + NAGEL
• Kerry Logistics Network Limited
• Agility
• McKesson Corporation
• Nippon Express
• C.H. Robinson Worldwide
• Sinotrans
• CEVA Logistics
FAQs:

1. What is the global Biopharmaceutical Third-Party Logistics market share in 2019?
Ans: Approximately, 94,400 Million USD.

2. What is the global Biopharmaceutical Third-Party Logistics market growth?
Ans: The global Biopharmaceutical Third-Party Logistics market is anticipated to grow with a CAGR of 5.7% in the forecast period and is likely to reach USD 147,086.19 million by the end of 2027.

3. Which supply chain segment is expected to dominate the global Biopharmaceutical Third-Party Logistics market during the forecast period?
Ans: The non-cold chain segment is considered to dominate the market with a revenue share of 81.3% due to the large-scale distribution of medicines and vaccines, high visibility, low-cost optimization, higher returns with lower risk.

4. Which region is expected to dominate the global Biopharmaceutical Third Party Logistics during the forecast period?
Ans: North America dominates the Biopharmaceutical Third-Party Logistics market owing to the dominance of biologics and pharmaceutical drug market together with high import and export facilities around the region.

5. What is the key driving factor for the growth of the global Biopharmaceutical Third-Party Logistics market?
Ans: The demand for warehouse robotics and mobile cloud solution to track the warehousing temperature and activities are the key factors driving the global Biopharmaceutical Third-Party Logistics market.

For More Information Visit @: Maximize Market Research Company

This Report Is Submitted By : Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

 

Article Estates
Logo
Shopping cart